We demonstrated that, in contrast to classical opioid receptors, ACKR3 isn't going to cause classical G protein signaling and isn't modulated with the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. In its place, we established that LIH383, an ACKR3-selective https://charlesg913cwf8.bloggerbags.com/profile